Virginia Allen Portner

Array ( [id] => 8621353 [patent_doc_number] => 08354266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Method for producing extracellular multi-enzyme complexes in host cells' [patent_app_type] => utility [patent_app_number] => 12/621805 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 4441 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12621805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320883 [patent_doc_number] => 20100196445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'SYSTEMS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/617511 [patent_app_country] => US [patent_app_date] => 2009-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10088 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20100196445.pdf [firstpage_image] =>[orig_patent_app_number] => 12617511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314539 [patent_doc_number] => 20100112006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Compositions of activated botulinum holotoxin type B (150 kD)' [patent_app_type] => utility [patent_app_number] => 12/590154 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7313 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112006.pdf [firstpage_image] =>[orig_patent_app_number] => 12590154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6475380 [patent_doc_number] => 20100284958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy' [patent_app_type] => utility [patent_app_number] => 12/610021 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 31980 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0284/20100284958.pdf [firstpage_image] =>[orig_patent_app_number] => 12610021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8016353 [patent_doc_number] => 08137675 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-20 [patent_title] => 'Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy' [patent_app_type] => utility [patent_app_number] => 12/608813 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 34 [patent_no_of_words] => 31978 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 264 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/137/08137675.pdf [firstpage_image] =>[orig_patent_app_number] => 12608813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6480063 [patent_doc_number] => 20100092517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Dose and localization of botulinum toxins in skin and muscle' [patent_app_type] => utility [patent_app_number] => 12/588345 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3616 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092517.pdf [firstpage_image] =>[orig_patent_app_number] => 12588345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6340064 [patent_doc_number] => 20100247546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'OPSONIC MONOCLONAL AND CHIMERIC ANTIBODIES SPECIFIC FOR LIPOTEICHOIC ACID OF GRAM POSITIVE BACTERIA' [patent_app_type] => utility [patent_app_number] => 12/572410 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21361 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20100247546.pdf [firstpage_image] =>[orig_patent_app_number] => 12572410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9874762 [patent_doc_number] => 08962026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Nanoemulsion therapeutic compositions and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/567571 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 78867 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12567571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9482533 [patent_doc_number] => 08728478 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Immunogenic Escherichia coli heat stable enterotoxin' [patent_app_type] => utility [patent_app_number] => 13/054983 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 18988 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573132 [patent_doc_number] => 20110268788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'IMMUNOTHERAPEUTIC AGENT SUITABLE FOR THE PRIMARY PROPHYLAXIS OF TUBERCULOSIS' [patent_app_type] => utility [patent_app_number] => 13/120476 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4046 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268788.pdf [firstpage_image] =>[orig_patent_app_number] => 13120476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7761910 [patent_doc_number] => 08114657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Antimicrobial protein compositions and production thereof from marine bacteria' [patent_app_type] => utility [patent_app_number] => 13/060448 [patent_app_country] => US [patent_app_date] => 2009-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4196 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114657.pdf [firstpage_image] =>[orig_patent_app_number] => 13060448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373729 [patent_doc_number] => 20090311290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Urogenital or anorectal transmucosal vaccine delivery system' [patent_app_type] => utility [patent_app_number] => 12/583219 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4281 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311290.pdf [firstpage_image] =>[orig_patent_app_number] => 12583219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431613 [patent_doc_number] => 20100143413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'APPARATUS AND METHOD FOR TREATING A NEUROMUSCULAR DEFECT' [patent_app_type] => utility [patent_app_number] => 12/541221 [patent_app_country] => US [patent_app_date] => 2009-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5278 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143413.pdf [firstpage_image] =>[orig_patent_app_number] => 12541221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5970846 [patent_doc_number] => 20110151538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'AFFINITY PURIFICATION BY COHESIN-DOCKERIN INTERACTION' [patent_app_type] => utility [patent_app_number] => 13/056913 [patent_app_country] => US [patent_app_date] => 2009-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 19961 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20110151538.pdf [firstpage_image] =>[orig_patent_app_number] => 13056913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625960 [patent_doc_number] => 20100034854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'Compositions of activated botulinum holotoxin type B (150 KD)' [patent_app_type] => utility [patent_app_number] => 12/462560 [patent_app_country] => US [patent_app_date] => 2009-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7285 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20100034854.pdf [firstpage_image] =>[orig_patent_app_number] => 12462560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9369854 [patent_doc_number] => 20140079727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'NEW ENDOLYSIN PLYP40' [patent_app_type] => utility [patent_app_number] => 13/055646 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6392 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13055646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8956151 [patent_doc_number] => 08501926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-06 [patent_title] => 'Malaria vaccine' [patent_app_type] => utility [patent_app_number] => 13/120784 [patent_app_country] => US [patent_app_date] => 2009-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 15203 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13120784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571221 [patent_doc_number] => 08337862 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-25 [patent_title] => 'Method for treating knee joint pain caused by saphenous nerve entrapment' [patent_app_type] => utility [patent_app_number] => 12/506622 [patent_app_country] => US [patent_app_date] => 2009-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4516 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12506622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142254 [patent_doc_number] => 20110129500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'LAWSONIA INTRACELLULARIS BACTERIUM OF A NOVEL SEROTYPE, VACCINE BASED ON THAT BACTERIUM, ANTIBODIES SUITABLE FOR DIAGNOSING THE NOVEL LAWSONIA INTRACELLULARIS SEROTYPE AND HYBRIDOMAS FOR PRODUCING THE SAID ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/054979 [patent_app_country] => US [patent_app_date] => 2009-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3571 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129500.pdf [firstpage_image] =>[orig_patent_app_number] => 13054979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003692 [patent_doc_number] => 20110118449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'FERRITIN 2 FOR THE HOST IMMUNIZATION AGAINST TICKS' [patent_app_type] => utility [patent_app_number] => 13/000813 [patent_app_country] => US [patent_app_date] => 2009-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1015 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118449.pdf [firstpage_image] =>[orig_patent_app_number] => 13000813 [rel_patent_id] =>[rel_patent_doc_number] =>)